Puma Shareholders Face Dividend Suspension Amid Strategic Overhaul

Investors in the sportswear giant Puma are being tested as the company navigates a challenging period. Confronted with a deeply disappointing fiscal 2025, the MDax-listed group has announced it will suspend its dividend payment entirely. The outlook for the current year offers little solace, with management already preparing the market for continued operational losses.

Strategic Pivot Coincides with Financial Strain

Undeterred by the financial pressures, the company is pushing forward with a significant structural reorganization. At its Herzogenaurach headquarters, Puma is splitting its Running and Training divisions into two independent business units. This move towards a more focused operational model is designed to enhance collaboration with key partners, such as the fitness race series HYROX, by improving market responsiveness.

The first concrete evidence of whether newly implemented cost-efficiency programs are taking hold during this transitional year will come on April 30, 2026, when Puma releases its first-quarter results. Until then, the stock’s potential for recovery remains heavily constrained by the bleak earnings forecast.

Should investors sell immediately? Or is it worth buying Puma?

A Transition Year Weighs on Market Sentiment

Immediate improvement appears unlikely. Management has formally designated 2026 as a transition year, projecting a further slight decline in revenue and an operating loss (EBIT) ranging between €50 million and €150 million. Concurrently, the firm is channeling approximately €200 million into bolstering its digital infrastructure and direct-to-consumer sales channels.

The capital market has reacted negatively to these prospects. The stock shed 10.35% of its value in the past week alone. Closing at €19.80 on Friday, the share price now trades below the technically significant 200-day moving average of €20.90.

Bottom Line Impacted by Steep Declines

The figures from the past fiscal year paint a sobering picture. On a currency-adjusted basis, revenue contracted by 8.1% to approximately €7.3 billion. Burdened by strategic adjustments and a weaker gross profit margin, the reported operating result (EBIT) fell to a loss of €357.2 million. The logical, yet painful, consequence for shareholders is that no dividend will be paid for 2025. This follows a distribution of €0.61 per share the previous year.